no not until later in the year and based on no further grants from dod usa but wouldnt rule that out further phase 3 Indonesian trial on diabetic ulcers not cash flow draining as mostly paid for by them further r&d rebates due also to boost cash kitty before june so in. My view this release on absssi trials is not a fluff and pump as a precursor to a cap raise but what would i know anyway
RCE Price at posting:
45.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)